艾森曼格综合征患者的慢性α1受体阻滞剂治疗
Chronic alpha 1 blockade in a patient with Eisenmenger syndrome.
作者信息
Watanabe K, Mori C, Haneda N, Inoue M, Kishida K, Hayashi Y, Ozasa H
机构信息
Department of Pediatrics, Shimane Medical University, Izumo, Japan.
出版信息
Pediatr Cardiol. 1991 Jan;12(1):52-3. doi: 10.1007/BF02238502.
PMID:1671797
Abstract
In an 18-year-old male with Eisenmenger syndrome cyanosis and erythrocytosis were increasing. The erythrocytosis diminished following oral bunazosin and phlebotomy was not needed during the treatment. When bunazosin was stopped, the erythrocytosis increased, but when it was resumed, the erythrocytosis and general fatigue diminished.
摘要
一名18岁患有艾森曼格综合征的男性患者，发绀和红细胞增多症逐渐加重。口服布那唑嗪后红细胞增多症减轻，治疗期间无需进行放血治疗。停用布那唑嗪后，红细胞增多症又加重，但重新服用后，红细胞增多症及全身乏力症状减轻。
Zotero 插件